Clinical Trials · NCT00033605

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Name: Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Octreotide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Alliance for Clinical Trials in Oncology
Enrollment: 130
Start date: Apr 2002
Locations: See registry
Primary endpoint: Reduction of diarrhea as measured by NCI CTC version 2.0 weekly during pelvic radiotherapy

View Octreotide compound reference